The U.S. Food and Drug Administration on Tuesday approved Abeona Therapeutics' gene therapy for a rare skin disorder.

Spotify forecast monthly active users and premium subscribers for the second quarter above market estimates on Tuesday, signaling strong demand for its audio streaming services as it leans on AI features to drive growth.

U.S. drugmaker Merck is investing $1 billion in a new Delaware plant to expand its domestic production as it prepares to deal with the looming impact from President Donald Trump's tariffs, the Wall Street Journal reported on Tuesday.

HOUSTON--(BUSINESS WIRE)--Enterprise Products Partners L.P. (“Enterprise”) (NYSE: EPD) today announced its financial results for the three months ended March 31, 2025. Enterprise reported net income attributable to common unitholders of $1.4 billion, or $0.64 per common unit on a fully diluted basis, for the first quarter of 2025, compared to $1.5 billion, or $0.66 per common unit on a fully diluted basis, for the first quarter of 2024. Distributable Cash Flow (“DCF”) was $2.0 billion for the f.

The Art Conservation Project will help restore art from around the world; Sydney Opera House and National Portrait Gallery among recipients CHARLOTTE, N.C. , April 29, 2025 /PRNewswire/ -- Sixteen cultural institutions have been named as grant recipients of the 2025 Bank of America Art Conservation Project.

Sales of $9.8 Billion, Reported Sales Up 8%, Organic1 Sales Up 4%, Exceeding High End of Previous Guidance Earnings Per Share of $2.22 and Adjusted Earnings Per Share1 of $2.51, Exceeding High End of Previous Guidance by 26 Cents Backlog Up 8% Excluding Acquisitions, Led by Strength in Building Automation and Energy and Sustainability Solutions Businesses Deployed $2.9 Billion of Capital to Share Repurchases, Dividends, and Capital Expenditures; Announced the $2.2 Billion Acquisition of Sundyne Company Maintains Full-Year Organic Growth Guidance and Raises Adjusted Earnings Per Share Guidance, Including Net Expected Impact of Tariffs, Mitigation Actions, and Global Demand Uncertainty …

- ZEVASKYN fills a critical need for people living with RDEB, a debilitating dermatological condition with no cure - - Approval based on the pivotal Phase 3 VIITAL™ study, showing ZEVASKYN resulted in significant wound healing and pain reduction after a single treatment with a favorable safety profile - - ZEVASKYN to be available through Qualified Treatment Centers beginning in 3Q 2025 - - Abeona Assist™ patient services program offers personalized support for eligible patients and families throughout their treatment journey with ZEVASKYN - - Rare Pediatric Disease Priority Review Voucher (PRV) granted by FDA - - Abeona Therapeutics ® …

MINNEAPOLIS , April 29, 2025 /PRNewswire/ -- Polaris Inc. (NYSE: PII) reported first quarter 2025 financial results today through an earnings release posted on the Company's Investor Relations website at ir.polaris.com. The earnings release will be furnished with the Securities and Exchange Commission on a Form 8-K and is available at sec.gov.

SHANGHAI , April 29, 2025 /PRNewswire/ -- Cango Inc. (NYSE: CANG) ("Cango" or the "Company"), a rapidly expanding leader in Bitcoin mining, announced the initiation of coverage by Apollo Insights, an independent equity research firm. Apollo Insights initiated coverage on Cango on April 22, 2025, following the release of its equity research report and investment thesis titled "Cango Catapults Into Bitcoin Mining".

Expands access to first customer using Philips MR Spectroscopy (MRS), demonstrating ease of Nociscan integration across multiple MRS platforms Nociscan now commercially available at 17 sites covering eight states and four countries BROOMFIELD, Colo., April 29, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today it has established a commercial agreement with the Spine Institute of Louisiana (SIL) in Shreveport, LA.

HUNTSVILLE, AL, April 29, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug optimization technology, announced that Steve Ledger, Chief Executive Officer, will present at the JonesResearch Hosts: Virtual CNS Day on April 29, 2025, at 12:00 p.m. EDT.

SAN FRANCISCO--(BUSINESS WIRE)--SentinelOne reveals the next-gen of Purple AI showcasing the first agentic AI capabilities to mirror the deep security reasoning and more.

LANCASTER, Pa.--(BUSINESS WIRE)--Armstrong World Industries, Inc. (NYSE:AWI), an Americas leader in the design and manufacture of innovative interior and exterior architectural applications including ceilings, specialty walls and exterior metal solutions, today reported first-quarter 2025 financial results highlighted by strong net sales and earnings growth. "We delivered a solid start to 2025 with double-digit net sales and earnings growth featuring strong Mineral Fiber AUV performance, manufa.

Total net revenue of $76.3 million from Q1 2025 driven by Ohtuvayre ® net sales of $71.3 million (+95% vs Q4 2024)

— Accelerated recurring organic revenue growth — — Reaffirmed 2025 Outlook — — Repurchased $50 million ordinary shares — LONDON , April 29, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today reported results for the first quarter ended March 31, 2025. Total revenues for the first quarter of 2025 was $593.7 million, compared to total revenues of $621.2 million for the first quarter of 2024.

BEIJING , April 29, 2025 /PRNewswire/ -- Quhuo Limited (Nasdaq: QH) ("Quhuo," the "Company," "we" or "our"), a leading gig economy platform focusing on local life services in China, today reported its unaudited financial results for the six months and full year ended December 31, 2024. Financial and Operational Highlights for the Second Half of 2024 Net income was RMB48.1 million (US$6.6 million), representing a year-over-year increase of 311.1% from RMB11.7 million.

HSINCHU, April 29, 2025 /PRNewswire-FirstCall/ -- ChipMOS TECHNOLOGIES INC. ("ChipMOS" or the "Company") (Taiwan Stock Exchange: 8150 and Nasdaq: IMOS), an industry leading provider of outsourced semiconductor assembly and test services ("OSAT"), today announced that it will report first quarter 2025 results and host a conference call after the close of trading on the Taiwan Stock Exchange on Tuesday, May 13, 2025.

ROSH HA'AIN, Israel , April 29, 2025 /PRNewswire/ -- Ceragon (NASDAQ: CRNT), a leading solutions provider of end-to-end wireless connectivity, today announced that its management will participate in the 20th Annual Needham Technology, Media, & Consumer 1x1 Conference being held May 8 - 13, 2025. Ronen Stein, Ceragon's Chief Financial Officer, will host virtual one-on-one meetings on Monday, May 12.

SAN MATEO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a first quarter 2025 total cash distribution of $0.47 per share. The following shows the key dates of the first quarter 2025 di.

DULUTH, Ga.--(BUSINESS WIRE)--National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) today announced that its Board of Directors has appointed Alex Wilkes as the Company's next Chief Executive Officer, effective August 1, 2025, and he will join the Company's Board at that time. Mr. Wilkes succeeds Reade Fahs who will assume the role of Executive Chairman of the Board. Mr. Fahs will continue to work closely with Mr. Wilkes, ensuring a smooth transition. “National Visio.